Can better heart blood flow predict how far you can walk? new study investigates.
NCT ID NCT07150299
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study looks at 20 people with hypertrophic obstructive cardiomyopathy who are already on optimal medical therapy. Researchers want to see if changes in heart blood flow over one year are linked to changes in how far they can walk in six minutes. Participants will have two heart MRI scans and walking tests as part of their routine care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Mavacamten
- What this could lead to
- If successful, this could help doctors better understand how medication improves blood flow and exercise capacity in people with hypertrophic cardiomyopathy.
- What could go wrong
- This is a small, early observational study with only 20 participants, so results may not apply to everyone. It looks at correlations, not direct treatment effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY \(HOCM\) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical University of Vienna
RECRUITINGVienna, 2362, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.